# Didier Serteyn - Full Context for AI Agents

> This file provides comprehensive context about Didier Serteyn for AI agents.
> Source: TechWiki.ai - The Belgian Tech Encyclopedia
> Last updated: 2026-07-08

## Identity
- Name: Didier Serteyn
- Role: CEO
- Company: Revatis
- Location: Liège, Belgium
- LinkedIn: https://www.linkedin.com/in/didier-serteyn-98577b19

## Expertise
- Creativity and Innovation
- Stem Cells
- Exosomes
- Regenerative Medicine
- Research and Development (R&D)

## About
Didier Serteyn is chief executive of Revatis, based in Liège. He joined Revatis as chief scientific officer in 2014, a role he continues to hold, and became managing director in 2018. Since 2007 he has also been chief scientific officer of Bioptis, and since 2000 a managing partner of the Mont-le-Soie, Equine Research Center.

From October 1995 to October 2024 he was a professor at the University of Liège, holding the qualifications DVM, PhD, Dipl ECVAA and Dipl ECVSMR. He studied veterinary medicine at the University of Liège, completing his degree in 1982.

His stated areas of expertise are creativity and innovation, stem cells, exosomes, regenerative medicine, and research and development.

<!-- bio:generated -->

## Related Pages
Agents can crawl these for connected context:
- [company] Revatis: https://techwiki.ai/companies/revatis/llms.txt

## Recent News
- [2026-08-20] I am pleased to share that our abstract has been selected for an oral presentation at the 3rd World Congress on Targeting Extracellular… (https://www.linkedin.com/posts/didier-serteyn-98577b19_third-world-congress-targeting-extracellular-activity-7496185196967538688-4tY1)
- [2026-07-14] We decided some years ago to work in aseptic isolators GMPc for our C&G products in the aim to reduce the COGs and the final prices which… (https://www.linkedin.com/posts/didier-serteyn-98577b19_celltherapy-stemcells-genetherapy-activity-7482678910971834368-Ij4n)
- [2026-07-06] A new innovative orthobiologic is available via our Spin Off Company. A very interesting autologous product derived from mechanically… (https://www.linkedin.com/posts/didier-serteyn-98577b19_revatis-axovet-maps-activity-7479921184193671168-H8fu)
- [2026-07-06] Travailler en réseau d'entreprises est essentiel. Les relations humaines avant tout. Le business suivra ! (https://www.linkedin.com/posts/didier-serteyn-98577b19_equisfair-filiaeyreaezquestre-equestrian-activity-7479758134480396288-cDwb)
- [2026-06-15] EVs derived from mechanical activated platelets. A new orthobiologics available in veterinary medicine! #PRP #Extracellularvesicles… (https://www.linkedin.com/posts/didier-serteyn-98577b19_revatis-equinemedicine-veterinarymedicine-activity-7472266916456402944-LmqR)

## How to Reach
- LinkedIn: https://www.linkedin.com/in/didier-serteyn-98577b19
- Agent context: https://techwiki.ai/people/didier-serteyn/llms.txt
- Full context: https://techwiki.ai/people/didier-serteyn/llms-full.txt

---
Generated by TechWiki.ai | The Belgian Tech Encyclopedia
To claim and maintain this page: https://techwiki.ai/claim